Dragonite and the Postman's latest trailer features the special's gorgeous theme song written by a Tokyo Anime Award winner.

Ash’s Grass-type Pokémon tend to always be regional starter Pokémon, but these top-tier species would have made for excellent ...

While the original games suggest Pokemon can't speak human language, the anime producers tackled the issue of whether Pokemon are able to speak. According to Dogasu, the Pocket Monster manga by ...

Ash Ketchum is regarded as the hero of the original Pokémon anime, yet even he would struggle against the many powerful Trainers of the manga.

First, we'll show you how to watch the Pokemon series in order – including all 27 seasons, with the end of Ash's journey and Liko's ongoing adventure in Pokemon Horizons: The Series (season 2 of ...

Eli Lilly's small pop was due to the latest developments in the lab reported by Novo Nordisk (NYSE: NVO), which, like the U.S. company, is doing brisk business with a weight loss drug: Wegovy ...

If Eli Lilly has its way, this may be the future of obesity care. Eli Lilly makes some of the most powerful weight-loss drugs in the world. The company has pivoted dramatically over the past ...

Lily Allen is sharing details surrounding a recent visit to a treatment center. The singer discussed the visit on the latest episode of her BBC podcast “Miss Me?” with her cohost Miquita ...

But cards from the new Space-Time Smackdown set won’t be immediately tradeable. But cards from the new Space-Time Smackdown set won’t be immediately tradeable. Charles Pulliam-Moore is a ...

Eli Lilly is experiencing explosive growth thanks to its diabetes and obesity treatments. Beyond weight loss, the company is quietly building a fast-growing oncology business. This is an enormous ...

Boris Becker's ex-wife Lilly has won the German version of I'm A Celebrity... Get Me Out Of Here! after stealing the hearts of the nation. The former Wimbledon tennis star, 57, has endured a ...

Eli Lilly, the world’s biggest drugmaker by market value, reported higher-than-expected quarterly profit and issued a bullish earnings forecast. Sales of weight-loss drug Zepbound and diabetes ...